Prediabetes: A Benign Intermediate Stage or a Risk Factor in Itself?

Cureus. 2024 Jun 26;16(6):e63186. doi: 10.7759/cureus.63186. eCollection 2024 Jun.

Abstract

Prediabetes is a condition when the blood glucose levels are above the normal range but below the threshold for defining diabetes. Previously considered benign, it is now recognized to be associated with various macrovascular and microvascular complications, with increases in the risk of cardiovascular events, nephropathy neuropathy, and retinopathy. Early identification of prediabetics may help detect the risk for these future complications at an earlier stage. Moreover, therapeutic options for prediabetes are available, which can retard its progression to diabetes and the subsequent development of complications. Hence, we make a case for the early identification of prediabetes through screening methods and appropriate institution of management strategies.

Keywords: hemoglobin a1c (hba1c); homeostatic model assessment for insulin resistance (homa-ir); insulin-like growth factor (igf); intermediate; prediabetes risk.

Publication types

  • Review